homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


Subscriber content preview

November 17, 2020

Moderna vaccine shows overwhelming success

  • If the FDA allows emergency use of Moderna's or Pfizer's candidate, there will be limited, rationed supplies before the end of the year.
    • By LAURAN NEERGAARD
    AP Medical Writer

    Moderna said Monday its COVID-19 vaccine is proving highly effective in a major trial, a second ray of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide.

    The company said its vaccine appears to be 94.5% effective, according to preliminary data from Moderna's ongoing study. A week ago, competitor Pfizer Inc. announced its own vaccine appeared similarly effective — news that puts both companies on track to seek permission within weeks for emergency use in the U.S.


     
    . . .


    To read this story in full login or purchase a subscription.



    
    Email or user name:
    Password:
     
    Forgot password? Click here.